Cargando…

HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study

BACKGROUND: Interferon-γ release assays (IGRA) serve as immunodiagnostics of tuberculosis (TB) infection to identify individuals with latent TB infection (LTBI) eligible for preventive anti-TB therapy. In this longitudinal study of HIV-infected LTBI patients we have observed for possible progression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pullar, Nadine Durema, Steinum, Harald, Bruun, Johan Nikolai, Dyrhol-Riise, Anne Ma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273430/ https://www.ncbi.nlm.nih.gov/pubmed/25515915 http://dx.doi.org/10.1186/s12879-014-0667-0

Ejemplares similares

Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country
por: Dyrhol-Riise, Anne M, et al.
Publicado: (2010)

Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results
por: Gran, Gerd, et al.
Publicado: (2013)

A Plasma 5-Marker Host Biosignature Identifies Tuberculosis in High and Low Endemic Countries
por: Chendi, Bih H., et al.
Publicado: (2021)

Soluble Markers of the Toll-Like Receptor 4 Pathway Differentiate between Active and Latent Tuberculosis and Are Associated with Treatment Responses
por: Feruglio, Siri L., et al.
Publicado: (2013)

Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study
por: Schein, Yvette Louise, et al.
Publicado: (2018)

Casemix system in Nordic countries
por: Steinum, Olafr
Publicado: (2012)

1066 Delay in the Norwegian Immunisation Programme
por: Riise, Oystein
Publicado: (2014)

Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls
por: Wergeland, Ida, et al.
Publicado: (2016)

IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
por: Tonby, Kristian, et al.
Publicado: (2015)

Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection
por: Feruglio, S L, et al.
Publicado: (2015)

Diagnosis of extrapulmonary tuberculosis using the MPT64 antigen detection test in a high-income low tuberculosis prevalence setting
por: Hoel, Ida Marie, et al.
Publicado: (2020)

Evaluation of treatment response in extrapulmonary tuberculosis in a low-resource setting
por: Jørstad, Melissa Davidsen, et al.
Publicado: (2019)

MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar
por: Jørstad, Melissa Davidsen, et al.
Publicado: (2018)

Evaluating Latent Tuberculosis Infection Test Performance Using Latent Class Analysis in a TB and HIV Endemic Setting
por: Adams, Shahieda, et al.
Publicado: (2019)

Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area
por: Moon, Hyung Hwan, et al.
Publicado: (2017)

Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors
por: Lieske, Nora V., et al.
Publicado: (2015)

Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in Mycobacterium tuberculosis Infection and Disease
por: Nore, Kristin Grotle, et al.
Publicado: (2020)

IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting
por: Hoel, Ida Marie, et al.
Publicado: (2019)

Cataract development in Norwegian patients with congenital aniridia
por: Edén, Ulla, et al.
Publicado: (2014)

Monitoring of timely and delayed vaccinations: a nation-wide registry-based study of Norwegian children aged < 2 years
por: Riise, Øystein Rolandsen, et al.
Publicado: (2015)

Adenosine Deaminase Activity Is a Sensitive Marker for the Diagnosis of Tuberculous Pleuritis in Patients with Very Low CD4 Counts
por: Baba, Kamaldeen, et al.
Publicado: (2008)

Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study
por: Winje, Brita Askeland, et al.
Publicado: (2019)

The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection
por: Tonby, Kristian, et al.
Publicado: (2016)

Mycobacterial antigens in pleural fluid mononuclear cells to diagnose pleural tuberculosis in HIV co-infected patients
por: Mustafa, Tehmina, et al.
Publicado: (2020)

Monkeypox Outbreaks in Non-Endemic Countries: What Do We Know and What Do We Need?
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

Regulation of Gag- and Env-Specific CD8(+) T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy
por: Prebensen, Christian, et al.
Publicado: (2016)

Diagnosis of latent tuberculosis: Can we do better?
por: Al-Orainey, Ibrahim O.
Publicado: (2009)

The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study
por: Brekke, Kristin, et al.
Publicado: (2017)

Biomarkers for Clinical and Incipient Tuberculosis: Performance in a TB-Endemic Country
por: Wanchu, Ajay, et al.
Publicado: (2008)

Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area
por: Lauar, Isabela Dias, et al.
Publicado: (2021)

Monocytic myeloid‐derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase‐2 inhibitors
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2020)

Development of the Norwegian diet index and the Norwegian lifestyle index and evaluation in a national survey
por: Henriksen, Hege Berg, et al.
Publicado: (2023)

Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries
por: Banerjee, Rupa, et al.
Publicado: (2020)

Non-compliance with health surveillance is a matter of Biosafety: a survey of latent tuberculosis infection in a highly endemic setting
por: da Rocha, Sheila Sotelino, et al.
Publicado: (2011)

Patient-reported outcomes in palliative gastrointestinal stenting: a Norwegian multicenter study
por: Larssen, Lene, et al.
Publicado: (2011)

Genitourinary Tuberculosis: A Comprehensive Review of a Neglected Manifestation in Low-Endemic Countries
por: Mantica, Guglielmo, et al.
Publicado: (2021)

Imported Tungiasis in a Non-endemic Country
por: Adachi, Eisuke, et al.
Publicado: (2018)

Prevalence of Latent Tuberculosis Infection and Associated Risk Factors Among 1557 Nursing Students in a Context of Low Endemicity
por: Lamberti, Monica, et al.
Publicado: (2015)

Latent tuberculosis in adult hematopoietic stem cell transplantation recipients: Clinical experience from a previously endemic population
por: Mert, Duygu, et al.
Publicado: (2022)

National policies on the management of latent tuberculosis infection: review of 98 countries
por: Jagger, Ann, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5ft6bvutb61jomoq2bk7v67u12